Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin Therapy

New England Journal of Medicine

Volumn 303, Issue 23, 1980, Pages 1313-1318

  Rizza, Robert A ^a   Gerich, John E ^a   Haymond, Morey W ^a   Westland, Robert E ^a   Hall, Larry D ^a   Clemens, Anton H ^a   Service, F John ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ZINC SUSPENSION; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL PANCREAS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE SYSTEM; GLUCOSE BLOOD LEVEL; HUMAN CELL; MAJOR CLINICAL STUDY; NORMAL HUMAN; THERAPY;

EID: 0019133632     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198012043032301     Document Type: Article

References (29)

1. Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia. 1978; 15:143-152.
2. Malone J.I., Hellrung J.M., Malphus E.W., et al. Good diabetic control a study in mass delusion. J Pediatr. 1976; 88:943-947.
3. Matas A.J., Sutherland D.E.R., Najarian J.S. Current status of islet and pancreas transplantation in diabetes. Diabetes. 1976; 25:785-795.
4. Santiago J.V., Clemens A.H., Clarke W.L., Kipnis D.M. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes. 1979; 28:71-81.
5. Albisser A.M., Leibel B.S., Ewart T.G., et al. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974; 23:397-404.
6. Pfeiffer E.F., Thum C., Clemens A.H. The artificial beta cell — a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res. 1974; 6:339-342.
7. Mirouze J., Selam J.L., Pham T.C., Cavadore D. Evaluation of exogenous insulin homeostasis by the artificial pancreas in insulin-dependent diabetes. Diabetologia. 1977; 13:273-278.
8. Irsigler K., Kritz H. Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus. Diabetes. 1979; 28:196-203.
9. Pickup J.C., White M.C., Keen H., Parsons J.A., Alberti K.G.M.M. long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet. 1979; 2:870-873.
10. Champion M.C., Shepherd G.A.A., Rodger N.W., Dupre J. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes. 1980; 29:206-212.
11. Tamborlane W.V., Sherwin R.S., Genel M., Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med. 1980; 68:190-196.
12. Kitabchi A.E., Fisher J.N., Burghen G.A., Gaylord M.S., Blank N.M. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Diabetes Care. 1979; 2:421-424.
13. Anonymous. New insulin-delivery systems for diabetics. Lancet. 1979; 1:1275-1277.
14. Riley W.J., Silverstein J.H., Rosenbloom A.L. Ambulatory diabetes management by a pulse of subcutaneous insulin delivered by a portable pump: preliminary report. Diabetes Care. 1979; 2:272-274.
15. Pickup J.C., Keen H., Parsons J.A., Alberti K.G.M.M. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1978; 1:204-207.
16. Tamborlane W.V., Sherwin R.S., Genel M., Felig P. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet. 1979; 1:1258-1261.
17. Faber O.F., Binder C. C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus. Diabetes. 1977; 26:605-610.
18. Abraham E.C., Huff T.A., Cope N.D., Wilson J.B. Jr., Bransome E.D. Jr., Huisman T.H.J. Determination of the glycosylated hemoglobins (Hb AI) with a new microcolumn procedure: suitability of the technique for assessing the clinical management of diabetes mellitus. 1978; 27:931-937.
19. Service F.J., Rizza R.A., Westland R.E., et al. Considerations for the programming of an open-loop insulin infusion device from the Biostator Glucose Controller. Diabetes Care. 1980; 3:278-284.
20. Clemens A.H. Programmable open-loop micropump insulin delivery system. Diabetes Care. 1980; 3:359-361.
21. Nakagawa S., Nakayama H., Sasaki T., et al. A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes. 1973; 22:590-600.
22. Herbert V., Lau K.-S., Gottlieb C.W., Bleicher S.S. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965; 25:1375-1384.
23. Service F.J., Molnar G.D., Rosevear J.W., Ackerman E., Gatewood L.C., Taylor W.F. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970; 19:644-655.
24. Schlichtkrull J., Munck O., Jersild M. The M-value, an index of blood-sugar control in diabetics. Acta Med Scand. 1965; 177:95-102.
25. Hanna A.K., Zinman B., Nakhooda A.F., et al. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism. 1980; 29:321-332.
26. Slama G., Buu K.N.P., Tchobroutsky G., Delage A., Desplanque N. Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion. Diabetes Care. 1979; 2:251-255.
27. Schade D.S., Eaton R.P., Friedman N., Spencer W. The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man. Diabetes. 1979; 28:1069-1072.
28. Gerich J.E., Schultz T.A., Lewis S.B., Karam J.H. Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus. Diabetologia. 1977; 13:537-544.
29. Nelson J.D., Marliss E.B., Albisser A.M., Zinman B. Role of continuous component in subcutaneous “open-loop” insulin delivery. Lancet. 1980; 1:1383-1386.